BFRI
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$1.61
+6.62%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+65.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jul 29, 2026 | Luebbert Hermann · director, officer: CEO & Chairman | M-Exempt | 62,500 | $0.00 |
| Jul 29, 2026 | Leffler Eugene Frederick · officer: Chief Financial Officer | M-Exempt | 31,250 | $0.00 |
| Mar 6, 2026 | Hoffman Beth J. · director | A-Award | 20,000 | $0.90 |
| Mar 6, 2026 | Lanckriet Heikki · director | A-Award | 20,000 | $0.90 |
| Mar 6, 2026 | Leffler Eugene Frederick · officer: Chief Financial Officer | A-Award | 62,500 | $0.00 |
| Mar 6, 2026 | Leffler Eugene Frederick · officer: Chief Financial Officer | M-Exempt | 87,500 | $0.00 |
| Mar 6, 2026 | BORER JOHN J III · director | A-Award | 20,000 | $0.90 |
| Mar 6, 2026 | Luebbert Hermann · director, officer: CEO & Chairman | M-Exempt | 137,500 | $0.00 |
| Mar 6, 2026 | Weber Kevin Daniel · director | A-Award | 20,000 | $0.90 |
| Mar 6, 2026 | Luebbert Hermann · director, officer: CEO & Chairman | A-Award | 125,000 | $0.00 |
| Mar 6, 2026 | Jones George Patrick · officer: Chief Commercial Officer | A-Award | 50,000 | $0.00 |
| Sep 18, 2025 | Biofrontera AG · director, 10 percent owner: | Purchase | 3,019 | $0.00 |
| Sep 16, 2025 | Leffler Eugene Frederick · officer: Chief Financial Officer | M-Exempt | 87,500 | $0.00 |
| Sep 16, 2025 | Jones George Patrick · officer: Chief Commercial Officer | A-Award | 100,000 | $1.00 |
| Sep 16, 2025 | Weber Kevin Daniel · director | A-Award | 20,000 | $1.00 |
| Sep 16, 2025 | Luebbert Hermann · director, officer: CEO & Chairman | M-Exempt | 137,500 | $0.00 |
| Sep 16, 2025 | Luebbert Hermann · director, officer: CEO & Chairman | A-Award | 125,000 | $0.00 |
| Sep 16, 2025 | Leffler Eugene Frederick · officer: Chief Financial Officer | A-Award | 62,500 | $1.00 |
| Sep 16, 2025 | Lanckriet Heikki · director | A-Award | 20,000 | $1.00 |
| Sep 16, 2025 | Hoffman Beth J. · director | A-Award | 20,000 | $1.00 |
| Sep 16, 2025 | BORER JOHN J III · director | A-Award | 20,000 | $1.00 |
| Jul 16, 2024 | Hoffman Beth J. · director | A-Award | 20,000 | $1.38 |
| Jul 16, 2024 | BORER JOHN J III · director | A-Award | 20,000 | $1.38 |
| Jul 16, 2024 | Luebbert Hermann · director, officer: CEO & Chairman | A-Award | 275,000 | $1.38 |
| Jul 16, 2024 | Weber Kevin Daniel · director | A-Award | 20,000 | $1.38 |
| Jul 16, 2024 | Lanckriet Heikki · director | A-Award | 20,000 | $1.38 |
| Jul 16, 2024 | Leffler Eugene Frederick · officer: Chief Financial Officer | A-Award | 175,000 | $1.38 |
| May 22, 2024 | Luebbert Hermann · director, officer: CEO & Exec. Chairman | M-Exempt | 4,771 | $0.00 |
| May 22, 2023 | Luebbert Hermann · director, officer: Executive Chairman | M-Exempt | 95,420 | $0.00 |
| May 22, 2023 | Monaco Erica L. · officer: Chief Executive Officer | M-Exempt | 76,336 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 3Increased 7Reduced 1Sold out 12
| Filer | Action | Shares | Filed |
|---|---|---|---|
| ROSALIND ADVISORS, INC. | Increased | 1,163,962 | May 14, 2026 |
| AIGH CAPITAL MANAGEMENT LLC | Unchanged | 915,210 | Apr 30, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 109,300 | May 15, 2026 |
| CITADEL ADVISORS LLC | New Position | 104,941 | Sep 2, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 61,697 | May 8, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 52,254 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 38,574 | May 15, 2026 |
| XTX TOPCO LTD | Increased | 22,493 | May 15, 2026 |
| CITIGROUP INC | Increased | 11,837 | May 11, 2026 |
| SANCTUARY ADVISORS, LLC | Increased | 10,200 | May 5, 2026 |
| BLACKROCK, INC. | Unchanged | 4,622 | May 13, 2026 |
| UBS GROUP AG | Reduced | 1,540 | May 5, 2026 |
| SBI SECURITIES CO., LTD. | Increased | 305 | Apr 28, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold Out | 0 | May 15, 2026 |
| Sanctuary Advisors, LLC | Sold Out | 0 | May 5, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 29, 2026